Delivery Order SPE2DX22D0010-SPE2D826FBG47
Award Date 11/24/25
Potential Completion Date 11/25/25
Potential Value $9.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Quillivant XR Oral Suspension 60ml 5mg/ml, a pharmaceutical product used in the treatment of attention deficit hyperactivity disorder. This competitively awarded, non-set-aside delivery order carries a ceiling value of $8,807.10 with firm fixed pricing and an ultimate completion date of August 14, 2025. The contract is performed out of...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in 60 ml quantities, valued at $2,915.25. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is scheduled for completion by June 3, 2025, with performance taking place at AmerisourceBergen's corporate office location in...
- The Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in a 120 ml quantity. This is a firm fixed-price delivery order with a ceiling value of $3,253.59 and an ultimate completion date of September 19, 2025. The award represents a non-competitive delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension in 60 mL quantities, with a ceiling value of $3,991.48. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for ultimate completion by September 23, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in a 120 ml quantity, valued at $2,638.27. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and is classified as a delivery order, with an ultimate completion date of November 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Quillivant XR oral suspension (60mL, 5mg/mL), a medication used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order has a ceiling value of $8,284.62 and is scheduled for completion by October 28, 2025. The contract was placed with AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Quillivant XR Oral Suspension 60ML 5MG/ML, a medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $2,736.97, is not set-aside and represents a competitive award under an existing indefinite delivery contract vehicle. The product will be delivered to the vendor's headquarters in Conshohocken,...
- The Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Quillivant XR Oral Suspension (60ML, 5MG/ML), an FDA-approved medication for attention-deficit/hyperactivity disorder treatment. This firm fixed-price delivery order, valued at $6,709.14, represents a non-competitive set-aside contract with an ultimate completion date of November 10, 2025. The product will be delivered to AmerisourceBergen's location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension (60 mL) with a ceiling value of $1,431.19. This is a firm fixed-price, non-set-aside delivery order that will be fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of November 6, 2025. The delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in a 60 ml quantity. This competitively awarded, firm fixed-price contract carries a ceiling value of $1,526.88 and is scheduled for completion by October 27, 2025. The contract was issued as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999...